Stable transduction of recombinant adeno-associated virus into hematopoietic stem cells from normal and sickle cell patients

Biology of Blood and Marrow Transplantation

Volumn 2, Issue 1, 1996, Pages 24-30

  Luhovy, M ^a,b   McCune, S ^a   Dong, J Y ^a   Prchal, J F ^c   Townes, T M ^a   Prchal, J T ^a,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c MCGILL UNIVERSITY   (Canada)

^d 513 Tinsley Harrison Towers ^*  (United States)

Author keywords

AAV vector; Gene therapy; Hematopoietic stem cells; Sickle cell disease

Indexed keywords

EID: 0009057308     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dexter TM, Spencer E: Growth and differentiation in the hemopoietic system. Annu Rev Cell Biol 3:423, 1987.
2. Lemischka IR, Raulet DH, Mulligan R: Development potential and dynamic behavior of hematopoietic stem cells. Cell 45:917, 1986.
3. Gartner S, Kaplan HS: Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA 77:4756, 1980.
4. Eaves CH, Cashman JD, Eaves AC: Methodology of long-term culture of human hemopoietic cells. J Tissue Cult Meth 13:5, 1991.
5. Sutherland HJ, Hogge DE, Cook D, Eaves CJ: Alternative mechanisms with and without Steel factor support primitive human hematopoiesis. Blood 81:1465, 1993.
6. Hughes PFD, Thacker JD, Hogge D, Sutherland HJ, Thomas TE, Lansdorp PM, Eaves CJ, Humphries RK: Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures. J Clin Invest 89:1817, 1992.
7. Correa PN, Eskinazi D, Axelrad AA: Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: Studies in an improved serum-free medium. Blood 83:99, 1994.
8. Correa P, Axelrad A: Production of erythroid burst by progenitor cells from adult human peripheral blood in an improved serum-free medium. Role of IGF-I. Blood 78:2823, 1991.
9. Prchal JT, Prchal JF: Evolving understanding of the cellular defect in polycythemia vera: Implications for its clinical diagnosis and molecular pathophysiology. Blood 83:1, 1994.
10. + progenitor cells under serum-free culture conditions. Prog Clin Biol Res 389:351, 1994.
11. + hematopoietic stem cells from human peripheral blood by high-gradient magnetic sorting. Cytometry 14:384, 1993.
12. Baum CM, Weissman IL, Tsukamuto AS, Buckle AM, Peault B: Isolation of a candidate hematopoietic stem cell population. Proc Natl Acad Sci USA 89:2804, 1992.
13. Samulski RJ: Adeno-associated virus: Integration at a specific chromosomal locus. Curr Opin Genet Dev 3:74, 1993.
14. Muzyczka N: Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 158:97, 1992.
15. Berger SL, Kimmel AR: Methods in Enzymology, Volume 152: Guide to Molecular Cloning Techniques. Orlando: Academic Press, 367, 1987.
16. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632, 1988.
17. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE: Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137, 1992.
18. Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heimfeld S, Srivastava A, Broxmeyer HE: Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 179:1867, 1994.
19. Miller JL, Donahue RE, Sellers SE, Samulski RJ, Young NS, Nienhuis AW: Recombinant adeno-associated virus (rAAV)-mediated expression of a human γ-globin gene in human progenitor-derived erythroid cells. Proc Natl Acad Sci USA 91:10183, 1994.
20. Goodman S, Xiao X, Donahue RE, Moulton A, Miller J, Walsh C, Young NS, Samulski RJ, Nienhuis AW: Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84:1492, 1994.
21. Hanania EG, Kavanagh J, Hortobagyi G, Giles RE, Champlin R, Deisseroth AB: Recent advances in the application of gene therapy to human disease. Am J Med 99:537, 1995.
22. Leboulch P, Huang GM, Humphries RK, Oh YH, Eaves CJ, Tuan DY, London IM: Mutagenesis of retroviral vectors transducing human β-globin gene and β-globin locus control region derivatives results in stable transmission of an active transcriptional structure. EMBO J 13:3065, 1994.
23. McCune S, Townes TM: Retroviral vector sequences inhibit human β-globin gene expression in transgenic mice. Nucleic Acids Res 22:4477, 1994.
24. Perrine RP, Brown MK, Clegg JB: Benign sickle-cell anaemia. Lancet 2:1163, 1972.
25. Enver T, Ebens AJ, Forrester WC, Stamatoyannopoulos G: The human β-globin locus activating region alters the developmental fate of a human fetal globin gene in transgenic mice. Proc Natl Acad Sci USA 86:7033, 1989.
26. Watson J: The significance of the paucity of sickle cells in newborn Negro infants. Am J Med Sci 215:419, 1948.
27. Went LN, MacIver JE: An unusual type of hemoglobinopathy resembling sickle cell-thalassemia disease in a Jamaican family. Blood 13:559, 1958.
28. Charache S: Fetal hemoglobin sickling, and sickle cell disease. Adv Pediatr 37:1, 1992.
29. Bunn HF, Forget BG: Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia: WB Saunders, 74, 1986.
30. Platt LS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639, 1994.
31. McCune SL, Reilly MP, Chomo MJ, Asakura T, Townes TM: Recombinant human hemoglobins designed for gene therapy of sickle cell disease. Proc Natl Acad Sci USA 91:9852, 1994.